Navigation Links
Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference
Date:11/23/2014

HAYWARD, Calif., Nov. 23, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), announced today that Paul F. Truex, President and Chief Executive Officer, will present a corporate update at the 2014 Annual Piper Jaffray Healthcare Conference.

Anthera will present at 4:30PM ET, December 3rd, at the Palace Hotel in New York City.

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious and life-threatening diseases, including lupus, lupus with glomerulonephritis, IgA nephropathy, and exocrine pancreatic insufficiency due to cystic fibrosis.

Safe Harbor Statement

Any statements contained in this press release that refer to future events or other non-historical matters, including statements that are preceded by, followed by, or that include such words as "estimate," "intend," "anticipate," "believe," "plan," "goal," "expect," "project," or similar statements, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on Anthera's expectations as of the date of this press release and are subject to certain risks and uncertainties that could cause actual results to differ materially as set forth in Anthera's public filings with the SEC, including Anthera's Annual Report on Form 10-K for the year ended December 31, 2013.  Anthera disclaims any intent or obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as required by applicable law.

CONTACT: Dennis Lutz of Anthera Pharmaceuticals, Inc., dlutz@anthera.com or 510.856.5598.

 


'/>"/>
SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
2. Anthera Announces First Quarter 2012 Financial Report and Conference Call
3. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
4. Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
5. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
6. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
7. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
8. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
10. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
11. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2018)... , ... November 29, 2018 , ... Windsor Gardens Healthcare ... located in North Hollywood, CA, announced today they were selected by the California Association ... in a new Volunteer Engagement Project. , The California Department of Public Health ...
(Date:11/28/2018)... ... ... Satin Fine Foods, a manufacturer of cake decorating products based in The Hudson ... 28th, 2018 at the HVNY office in Walden NY. , The proceeds were generated ... and CEO of Satin Fine Foods, Inc. , “Giving back is an essential part ...
(Date:11/28/2018)... ... November 28, 2018 , ... ... Israel’s Sheba Medical Center, Tel HaShomer this week to form a collaboration between ... home country, the Democratic Republic of Congo. , On Thursday, November 29, ...
Breaking Medicine Technology:
(Date:12/6/2018)... , ... December 06, 2018 , ... ... Medicare Analytic Consultant Senior of Blue Cross and Blue Shield of Kansas City, ... on Tuesday, December 11, 2018 at 2:15pm PT at the Fairmont Grand Del ...
(Date:12/5/2018)... ... December 05, 2018 , ... Adam Devlin , ... reappointed to serve on Philadelphia Mayor James F. Kenney’s Commission on People with ... identify with a cognitive or physical disability. Devlin serves as the chair of ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... of the first plastic surgery practices in Houston to offer the BodyTitePRO treatment. ... his patients an innovative range of surgical and noninvasive techniques to improve the ...
(Date:12/5/2018)... PARK, Minn. (PRWEB) , ... December 05, 2018 , ... ... original, engaging, personalized fitness content to the masses. Wellbeats , which has delivered ... has released a new Wellbeats consumer app. Available now in the Apple App ...
(Date:12/5/2018)... ... 05, 2018 , ... Northeast Delta Human Services Authority will ... Monroe Baptist Church, 210 Finks Hideaway Rd, Monroe, LA 71203. , The training ... educate and equip faith leaders to address substance abuse prevention, support and recovery ...
Breaking Medicine News(10 mins):